PTCT: Sephience’s strong launch and global expansion drive raised guidance and future growth
Sephience’s launch is outperforming prior PKU therapies, driving raised revenue guidance and global expansion. Real-world and clinical data reinforce its broad applicability, while pipeline progress and a strategic acquisition support future growth.Based on PTC Therapeutics, Inc. [PTCT] Morgan Stan…
Sephience’s launch is outperforming prior PKU therapies, driving raised revenue guidance and global expansion. Based on PTC Therapeutics, Inc. [PTCT] Morgan Stan…